Heart Test Laboratories, Inc. financial data

Symbol
HSCS, HSCSW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
550 Reserve St, Suite 360, Southlake, Texas
State of incorporation
Texas
Fiscal year end
April 30
Latest financial report
10-K - Q1 2024 - Jul 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 224 % +25.7%
Quick Ratio 29.8 % -6.4%
Debt-to-equity 83.4 % -75%
Return On Equity -192 % +70.3%
Return On Assets -105 % +29.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 856K shares -91.7%
Common Stock, Shares, Outstanding 677K shares +568%
Entity Public Float 21.1M USD +17.9%
Common Stock, Value, Issued 677 USD +570%
Weighted Average Number of Shares Outstanding, Basic 353K shares +343%
Weighted Average Number of Shares Outstanding, Diluted 353K shares +343%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.7K USD +654%
Cost of Revenue 4.56K USD +500%
Research and Development Expense 2.88M USD +17%
Operating Income (Loss) -6.31M USD -3.15%
Nonoperating Income (Expense) -299K USD -24.1%
Net Income (Loss) Attributable to Parent -6.61M USD -3.95%
Earnings Per Share, Basic -19 USD/shares +76.3%
Earnings Per Share, Diluted -19 USD/shares +76.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.81M USD +250%
Accounts Receivable, after Allowance for Credit Loss, Current 14.7K USD
Inventory, Net 629K USD -6.98%
Other Assets, Current 40.4K USD 0%
Assets, Current 7.35M USD +173%
Property, Plant and Equipment, Net 98K USD +59.5%
Operating Lease, Right-of-Use Asset 462K USD -12.7%
Assets 9.5M USD +189%
Accounts Payable, Current 448K USD -29%
Accrued Liabilities, Current 398K USD +3.23%
Liabilities, Current 1.75M USD -4.43%
Operating Lease, Liability, Noncurrent 434K USD -19.1%
Liabilities 2.19M USD -28.5%
Retained Earnings (Accumulated Deficit) -67.4M USD -10.9%
Stockholders' Equity Attributable to Parent 7.32M USD +3074%
Liabilities and Equity 9.5M USD +189%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.4M USD +22.5%
Net Cash Provided by (Used in) Financing Activities 324K USD -93.7%
Net Cash Provided by (Used in) Investing Activities -4.91K USD +32.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 677K shares +568%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.08M USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.81M USD +250%
Deferred Tax Assets, Valuation Allowance 13.2M USD +15.1%
Operating Lease, Liability 536K USD -5.22%
Depreciation 7.34K USD +14.4%
Payments to Acquire Property, Plant, and Equipment 4.91K USD -32.2%
Lessee, Operating Lease, Liability, to be Paid 684K USD -12.5%
Property, Plant and Equipment, Gross 598K USD +12.1%
Operating Lease, Liability, Current 102K USD +246%
Lessee, Operating Lease, Liability, to be Paid, Year Two 165K USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 161K USD +64.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 147K USD -31.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 169K USD +2.49%
Deferred Tax Assets, Operating Loss Carryforwards 11.4M USD +17.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 174K USD +2.51%
Operating Lease, Payments 13.1K USD
Additional Paid in Capital 74.7M USD +22.5%
Interest Expense 354K USD +45.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%